Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental treatments for asthma

A A Floreani1, S I Rennard

  • 1Pulmonary and Critical Care Medicine Section, University of Nebraska Medical Center, Omaha 68198-5300, USA.

Current Opinion in Pulmonary Medicine
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sphingosylphosphorylcholine induces α-smooth muscle actin expression in human lung fibroblasts and fibroblast-mediated gel contraction via S1P2 receptor and Rho/Rho-kinase pathway.

Prostaglandins & other lipid mediators·2014
Same author

PDE4: a novel target in the treatment of chronic obstructive pulmonary disease.

Clinical pharmacology and therapeutics·2011
Same author

Epithelial cells modulate genes associated with NF kappa B activation in co-cultured human macrophages.

Immunobiology·2011
Same author

Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic.

Clinical pharmacology and therapeutics·2011
Same author

Candidate genes for COPD in two large data sets.

The European respiratory journal·2010
Same author

Statins inhibit matrix metalloproteinase release from human lung fibroblasts.

The European respiratory journal·2009
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

New asthma treatments target inflammation by focusing on inflammatory cells and their products. These novel therapies include various inhibitors and antagonists, offering potential for improved symptom control and steroid-sparing effects in managing asthma.

Area of Science:

  • Immunology
  • Pharmacology
  • Respiratory Medicine

Background:

  • Asthma pathogenesis is increasingly linked to inflammatory cells and their mediators.
  • Existing treatments aim to manage asthmatic inflammation with varying success and side effects.

Purpose of the Study:

  • To review emerging therapeutic strategies for asthma targeting inflammatory pathways.
  • To explore novel drug classes and approaches for treating asthma inflammation.

Main Methods:

  • Review of current literature on anti-inflammatory agents and novel asthma therapies.
  • Categorization of therapeutic approaches based on their mechanism of action.

Main Results:

  • Nonselective anti-inflammatory agents (cyclosporine, gold) show symptom reduction and steroid-sparing effects.

Related Experiment Videos

  • Novel agents like 5-lipoxygenase inhibitors and cysteinyl leukotriene receptor antagonists demonstrate efficacy.
  • Other promising approaches include neurokinin antagonists, phosphodiesterase inhibitors, and cytokine-targeted therapies.

    • Conclusions:

    • Diverse therapeutic strategies are evolving to combat asthma inflammation.
    • Novel agents offer potential for improved asthma management, including symptom control and reduced steroid dependence.
    • Future research may involve gene-directed strategies and specific molecular targets for asthma treatment.